BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25903652)

  • 1. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
    Chen Y; Hu XF; Wang Y; Chen HY; Yang L; Liu LZ; Cui CY; Liu DS; Liang SB
    BMC Cancer; 2015 Apr; 15():305. PubMed ID: 25903652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma.
    Liang SB; Deng YM; Zhang N; Lu RL; Zhao H; Chen HY; Li SE; Liu DS; Chen Y
    BMC Cancer; 2013 May; 13():260. PubMed ID: 23710879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
    He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
    Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of total tumor volume in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Liang SB; Teng JJ; Hu XF; Yang XL; Luo M; Fang XN; Liu DS; Chen Y; Fu LW
    BMC Cancer; 2017 Jul; 17(1):506. PubMed ID: 28754109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
    Xiao Y; Pan J; Chen Y; Lin S; Chen Y; Zong J; Fang Y; Guo Q; Chen B; Tang L
    Radiat Oncol; 2015 Sep; 10():204. PubMed ID: 26407897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy.
    Chen YP; Tang LL; Zhang WN; Mao YP; Chen L; Sun Y; Liu LZ; Li WF; Liu X; Zhou GQ; Guo R; Mai HQ; Shao JY; Lin AH; Li L; Ma J
    Medicine (Baltimore); 2015 Oct; 94(43):e1624. PubMed ID: 26512556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?
    Guo R; Sun Y; Yu XL; Yin WJ; Li WF; Chen YY; Mao YP; Liu LZ; Li L; Lin AH; Ma J
    Radiother Oncol; 2012 Sep; 104(3):294-9. PubMed ID: 22998947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
    Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
    Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
    Luo Y; Qin Y; Lang J
    Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of prevertebral space involvement in nasopharyngeal carcinoma based on intensity-modulated radiotherapy.
    Zhou GQ; Mao YP; Chen L; Li WF; Liu LZ; Sun Y; Chen Y; Tian L; Lin AH; Li L; Ma J
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1090-7. PubMed ID: 21864993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma.
    Liang SB; Chen LS; Yang XL; Chen DM; Wang DH; Cui CY; Xie CB; Liu LZ; Xu XY
    Radiother Oncol; 2021 Feb; 155():219-225. PubMed ID: 33217495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
    Liao JF; Ma L; Du XJ; Lan M; Guo Y; Zheng L; Xia YF; Luo W
    PLoS One; 2016; 11(1):e0146787. PubMed ID: 26824230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
    Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
    Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does MRI-detected cranial nerve involvement affect the prognosis of locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy?
    Zong J; Lin S; Chen Y; Wang B; Xiao Y; Lin J; Li R; Pan J
    PLoS One; 2014; 9(6):e100571. PubMed ID: 24963626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.
    Zong J; Lin S; Lin J; Tang L; Chen B; Zhang M; Zhang Y; Xu L; Chen Y; Xiao Y; Fang Y; Pan J
    Oral Oncol; 2015 Mar; 51(3):254-9. PubMed ID: 25467207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma.
    Liang SB; Zhang N; Chen DM; Yang XL; Chen BH; Zhao H; Lu RL; Chen Y; Fu LW
    Radiother Oncol; 2019 Mar; 132():223-229. PubMed ID: 30366725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Feng M; Wang W; Fan Z; Fu B; Li J; Zhang S; Lang J
    Radiat Oncol; 2013 Sep; 8():208. PubMed ID: 24007375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Tang LL; Guo R; Zhou G; Sun Y; Liu LZ; Lin AH; Mai H; Shao J; Li L; Ma J
    PLoS One; 2014; 9(10):e108375. PubMed ID: 25302611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.